Articles By Marcus Johnson

31. UF Researchers Develop Drug To Reverse Memory Loss Caused By Aging 4/28/2014

    A research team from the University of Florida is working on developing a drug that could help treat and reverse memory loss due to aging. The researchers state that they are studying compounds that could potentially help aging adults that don’t have Alzheimer’s or any other form of dementia.

32. Rutgers Antibiotics Grant Could Be As Much As $26 Million 4/28/2014

    Rutgers New Jersey Medical School has announced that it has received a five year grant that could amount to as much as $26 million. The grant was given by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

33. Johns Hopkins Drug Shows Potential Combatting Heart Disease 4/28/2014

    A research team at Johns Hopkins University is designing a heart disease drug that has the potential to dramatically change the way the medical community treats patients with cardiovascular problems.

34. GSU Researchers Develop New Measles Drug 4/28/2014

    Researchers at the Institute for Biomedical Sciences at Georgia State University, the Emory Institute for Drug Development, and the Paul-Ehrlich Institute in Germany have developed a new antiviral drug that can protect people infected with measles from getting sick. The drug can also stop those infected from spreading the disease to other people.

35. Blood Pressure Drug Found To Prevent Epilepsy After Brain Injury 4/28/2014

    A common blood pressure drug, Cozaar (losartan), has been found to prevent epilepsy and impede further brain damage caused by seizures in patients that already have epilepsy. It is estimated that between 10 to 25 percent of all epilepsy attacks are a direct result of serious head trauma. Seizures caused by epilepsy can create further brain damage and worsen current brain injuries.

36. NSTDA Discovers New Anti-Malaria Drug 4/23/2014

    Thailand’s state run National Science and Technology Development Agency, or NSTDA, has developed a new medication for malaria that will soon be tested in clinical trials. The medication, a chemical called P218, was designed to target the malarial enzyme and stop the disease’s DNA from replicating. Researchers have said that the drug can completely destroy malaria parasites, and it won’t be expensive for the country to manufacture.

37. BioAlliance Pharma Acquires Biopharmaceutical Firm Topotarget 4/21/2014

    French pharmaceutical company BioAlliance Pharma has agreed to acquire the Scandinavian biopharmaceutical firm Topotarget.

38. UAB Building Drug Discovery Center To Combat West Nile Virus And Influenza 4/15/2014

    The University of Alabama at Birmingham announced last month that it is building a new drug discovery center in order to develop drug treatments for viral infections with limited options for treatment.

39. Scientists Find Printing 3D Tumors Could Aid Cancer Research 4/15/2014

    Researchers at Drexel University have begun using 3D printing in order to further study the cancer cells that make up tumors.

40. Has Alzheimer's Research Been Focused On Wrong Protein? 4/14/2014

    Claude Wischik, a chair in mental health at the University of Aberdeen in Scotland, believes that 20 years of Alzheimer’s research has been focused on the wrong protein.